| Literature DB >> 32164277 |
Shuang Li1, Dong-Nan Cui1, Hidayat Ullah1,2, Jun Chen1, Shao-Fang Liu1,3, Douglas W Whitman4, Ze-Hua Zhang1, Xiong-Bing Tu1.
Abstract
We analyzed the transcriptomes of Romalea microptera grasshoppers after 8 years of artificial selection for either long or short thoraces. Evolution proceeded rapidly during the experiment, with a 13.3% increase and a 32.2% decrease in mean pronotum lengths (sexes combined) in the up- and down-selected colonies, respectively, after only 11 generations. At least 16 additional traits also diverged between the two colonies during the selection experiment. Transcriptomic analysis identified 693 differentially expressed genes, with 386 upregulated and 307 downregulated (55.7% vs. 44.3%), including cellular process, metabolic process, binding, general function prediction only, and signal transduction mechanisms. Many of the differentially expressed genes (DEGs) are known to influence animal body size.Entities:
Keywords: DEGs; ECM–receptor interaction; Mtor; PI3K-Akt; Romalea microptera; body size; genetic correlation; phenylalanine metabolism; rapid evolution; transcriptome
Year: 2020 PMID: 32164277 PMCID: PMC7142927 DOI: 10.3390/insects11030176
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Change in mean pronotum length of Romalea microptera grasshoppers during 8 years (11 generations) of artificial selection in the laboratory for either long- or short-pronotum length. See Section 2 for description of selection experiment and populations.
| Population | Year | Male | Female | ||
|---|---|---|---|---|---|
|
| Pronotum Length (mm) |
| Pronotum Length (mm) | ||
| Wild | 2005 | 20 | 17.8 ± 1.09 | 20 | 21.1 ± 2.10 |
| Parent (Lab) | 2006 | 50 | 18.2 ± 0.97 | 50 | 21.2 ± 1.33 |
| Large Colony Generation 11 | 2014 | 41 | 20.9 ± 1.17 | 46 | 23.7 ± 1.39 |
| Small Colony Generation 11 | 2014 | 31 | 12.5 ± 0.75 | 26 | 14.2 ± 0.70 |
Fold-change distribution of DEGs performing Illumina sequencing and de novo assembly for two colonies of Romalea microptera.
| Log2 (Fold Change) | 1–2 | 2–3 | 3–4 | 4–5 | >5 | Total | |
|---|---|---|---|---|---|---|---|
| LG vs. SG | Downregulated | 40 | 52 | 42 | 40 | 133 | 307 |
| Upregulated | 24 | 63 | 46 | 51 | 202 | 386 | |
| Total | 64 | 115 | 88 | 91 | 335 | 693 | |
Figure 1Number of unigenes of Romalea microptera explained and classified by Gene Ontology (GO) data library in different functional groups within the categories of biological process, cellular component, and molecular function.
Figure 2Percent of Romalea microptera’s unigenes in each functional category for expressivity and dominancy, explained and classified by the Keeper of the Grove (KOG) database.
Substantially enriched GO terms of DEGs.
| Term type | Description | DEGs Number | Percentage (%) | |
|---|---|---|---|---|
| Biological process | DNA integration | 0.0107 | 16 | 8.38 |
| Biological process | DNA metabolic process | 0.00174 | 49 | 25.65 |
| Biological process | RNA-dependent DNA replication | 0.00435 | 27 | 14.14 |
| Biological process | DNA replication | 0.0195 | 31 | 16.23 |
| Molecular function | DNA polymerase activity | 0.00174 | 30 | 15.71 |
| Molecular function | RNA-directed DNA polymerase activity | 0.00435 | 27 | 14.14 |
| Molecular function | Nucleotidyltransferase activity | 0.0216 | 32 | 16.75 |
Number of substantially enriched pathways along with number of genes of downregulated DEGs computed by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
| S. No. | Pathway Term | Gene Number | |
|---|---|---|---|
| 1 | Huntington’s disease | 0.0180808 | 2 |
| 2 | Phenylalanine metabolism | 0.0188286 | 1 |
| 3 | Other glycan degradation | 0.0198644 | 1 |
| 4 | Histidine metabolism | 0.026057 | 1 |
| 5 | Tyrosine metabolism | 0.037311 | 1 |
| 6 | Alanine, aspartate, and glutamate metabolism | 0.037311 | 1 |
| 7 | Tryptophan metabolism | 0.0423843 | 1 |
| 8 | Glycine, serine, and threonine metabolism | 0.0423843 | 1 |
| 9 | Cysteine and methionine metabolism | 0.0474316 | 1 |
| 10 | Hedgehog signaling pathway | 0.0494433 | 1 |
Number of substantially enriched pathways along with number of genes of upregulated DEGs computed by KEGG pathway analysis.
| S. No. | Pathway Term | Gene Number | |
|---|---|---|---|
| 1 | Fat digestion and absorption | 0.00031 | 2 |
| 2 | Glycerolipid metabolism | 0.000625 | 2 |
| 3 | Metabolic pathways | 0.000779 | 5 |
| 4 | ECM–receptor interaction | 0.00118 | 2 |
| 5 | Small cell lung cancer | 0.001293 | 2 |
| 6 | Amoebiasis | 0.001732 | 2 |
| 7 | Cell adhesion molecules (CAMs) | 0.003595 | 2 |
| 8 | mTOR signaling pathway | 0.003984 | 2 |
| 9 | Focal adhesion | 0.006768 | 2 |
| 10 | Pantothenate and CoA biosynthesis | 0.011402 | 1 |
| 11 | Steroid biosynthesis | 0.012595 | 1 |
| 12 | PI3K-Akt signaling pathway | 0.018149 | 2 |
| 13 | Galactose metabolism | 0.019132 | 1 |
| 14 | beta-Alanine metabolism | 0.019132 | 1 |
| 15 | Pathways in cancer | 0.023941 | 2 |
| 16 | ABC transporters | 0.027392 | 1 |
| 17 | Drug metabolism—other enzymes | 0.027979 | 1 |
| 18 | Carbohydrate digestion and absorption | 0.027979 | 1 |
| 19 | Retinol metabolism | 0.039076 | 1 |
| 20 | Bile secretion | 0.042555 | 1 |
| 21 | Complement and coagulation cascades | 0.047174 | 1 |